Key result
ACE inhibition and ANG II receptor blockade inhibited leukocyte-endothelial adherence produced by alveolar hypoxia, suggesting the renin-angiotensin system mediates AH-induced inflammation.
Why the study?
Does renin-angiotensin system inhibition reduce systemic microvascular inflammation induced by alveolar hypoxia in a rat model?
Does renin-angiotensin system inhibition reduce systemic microvascular inflammation induced by alveolar hypoxia in a rat model?
The study demonstrates that alveolar hypoxia-induced systemic inflammation is mediated by a blood-borne agent that activates mast cells and stimulates the renin-angiotensin system.
Answers are grounded in this paper and cite their sources.
Attenuates hypoxia-induced inflammation in rats; leaves open translation to human disease or practice change.
Alveolar hypoxia (AH) induces widespread systemic inflammation. Previous studies have shown dissociation between microvascular Po(2) and inflammation. Furthermore, plasma from AH rats (PAHR) induces mast cell (MC) activation, inflammation, and vasoconstriction in normoxic cremasters, while plasma from normoxic rats does not produce these responses. These results suggest that inflammation of AH is triggered by a blood-carried agent. This study investigated the involvement of the renin-angiotensin system (RAS) in the inflammation of AH. Both an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin II (ANG II) receptor blocker (ANG II RB) inhibited the leukocyte-endothelial adherence produced by AH, as well as the inflammation produced by PAHR in normoxic rat cremasters. MC stabilization with cromolyn blocked the effects of PAHR but not those of topical ANG II on normoxic cremasters, suggesting ANG II generation via MC activation by PAHR. This was supported by the observation that ACE inhibition and ANG II RB blocked the leukocyte-endothelial adherence produced by the MC secretagogue compound 48/80. These results suggest that the intermediary agent contained in PAHR activates MC and stimulates the RAS, leading to inflammation, and imply an RAS role in AH-induced inflammation.
No takes yet. Share an insight, caveat, or question.
González et al. (2007) studied Alveolar hypoxia-induced systemic microvascular inflammation. ACE inhibitor and ANG II receptor blocker was evaluated on Leukocyte-endothelial adherence. ACE inhibition and ANG II receptor blockade inhibited leukocyte-endothelial adherence produced by alveolar hypoxia, suggesting the renin-angiotensin system mediates AH-induced inflammation.
Synapse has enriched 10 related papers. Consider them for comparative context: